Hitoshi Kawazoe

13PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsInnate immunityPacific Peoples medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 18, 2026
Attitudes of Older Patients and Caregivers in Japan Towards Deprescribing: A Cross-Sectional Study.

|Jul 30, 2026
Preventive Effects of Non-sedating and Sedating Histamine H1 Receptor Antagonists Premedication for Subcutaneous Daratumumab-Associated Infusion-Related Reactions: A Prospective Observational Study.

|May 25, 2026
Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study.

|Apr 03, 2026
Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.

Shinya Takada, Izumi Nasu, Ryuji Uozumi

|Feb 06, 2026
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment.

Shinya Takada, Kaori Takahashi, Ryuji Uozumi

|Nov 21, 2025
Proton Pump Inhibitors Attenuate the Effectiveness of Nivolumab Monotherapy in Patients with Advanced Gastric Cancer: A Retrospective Study.

Mikumi Yamaguchi, Hitoshi Kawazoe, Yusuke Kasai

Pageof 3

Frequent Collaborators

3 joint publications

Yuta Yokoyama

3 joint publications

Aya Jibiki

3 joint publications

Sayo Suzuki

3 joint publications

Tomonori Nakamura